Treatment of chemotherapy-refractory metastatic urothelial tumors.
Patients with unresectable bladder carcinoma unresponsive to standard chemotherapy have a short survival, but recent clinical trials of salvage treatment have produced some good results. Changes in the dosage of M-VAC; 5-fluorouracil, alpha-interferon, and cisplatin; and gallium nitrate show promise.